The Value of Genetic and Genomic Technologies

Knowing one's genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM's Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice.

Table of Contents

• Front Matter
• 1 Introduction
• 2 Tumor-Based Screening for Lynch Syndrome
• 3 Pharmacogenomic Testing to Guide Warfarin Dosing
• 4 Genomic Profiling
• 5 Closing Remarks
• References
• Appendix A: Workshop Agenda
• Appendix B: Speaker Biographical Sketches
• Appendix C: Lynch Syndrome Topic Brief
• Appendix D: Warfarin Topic Brief
• Appendix E: Genomic Profiling Topic Brief
<